1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Metastatic Cancer – Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Metastatic Cancer - Pipeline Review, H2 2012, provides an
overview of the indication’s therapeutic pipeline. This report provides information
on the therapeutic development for Metastatic Cancer, complete with latest updates,
and special features on late-stage and discontinued projects. It also reviews key
players involved in the therapeutic development for Metastatic Cancer. Metastatic
Cancer - Pipeline Review, Half Year is built using data and information sourced from
Global Markets Direct’s proprietary databases, Company/University websites, SEC
filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources, put together by Global Markets
Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Metastatic Cancer.
- A review of the Metastatic Cancer products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
2. - Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Metastatic Cancer.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
Table of contents:
List of Tables 20
List of Figures 24
Introduction 25
Global Markets Direct Report Coverage 25
Metastatic Cancer Overview 26
Therapeutics Development 27
An Overview of Pipeline Products for Metastatic Cancer 27
Metastatic Cancer Therapeutics under Development by Companies 29
Metastatic Cancer Therapeutics under Investigation by Universities/Institutes 43
Metastatic Cancer Therapeutics – Products under Development by Companies 67
Metastatic Cancer Therapeutics – Products under Investigation by
Universities/Institutes 97
Companies Involved in Metastatic Cancer Therapeutics Development 150
Bristol-Myers Squibb Company 150
Johnson & Johnson 151
Boehringer Ingelheim GmbH 152
F. Hoffmann-La Roche Ltd. 153
Kyowa Hakko Kirin Co., Ltd. 154
Celsion Corporation 155
Abbott Laboratories 156
Vical Incorporated 157
Amgen Inc. 158
Sanofi-Aventis 159
3. Adherex Technologies Inc. 160
AstraZeneca PLC 161
Eli Lilly and Company 162
Viralytics Ltd. 163
GlaxoSmithKline plc 164
Tekmira Pharmaceuticals Corp. 165
Bionovo, Inc. 223
Cytokinetics, Inc 224
Telik, Inc. 225
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012
Respiratory Depression – Pipeline Review, H2 2012
Metastatic Cancer – Pipeline Review, H2 2012
Viral Infections – Pipeline Review, H2 2012
Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
4. Gastrointestinal Tract Cancer – Pipeline Review, H2 2012
Diabetes – Pipeline Review, H2 2012
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012
Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012
Malaria – Pipeline Review, H2 2012
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012
Dermatitis – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
